跳至主要内容
临床试验/EUCTR2011-005321-51-ES
EUCTR2011-005321-51-ES进行中(未招募)不适用

Treatment of osteoarthritis with allogeneic mesenchymal cells (MSV *). - Treatment of osteoarthritis with allogeneic mesenchymal cells (MSV *).

Parque Científico de la Universidad de Valladolid0 个研究点目标入组 30 人开始时间: 2011年11月22日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1. Gonarthrosis grade 2, 3 or 4 of Kellgren and Lawrence (Kellgren & Lawrence, 1957) assessed by two observers.
  • 2. Chronic painful knee mechanical properties.
  • 3. No local or systemic septic process.
  • 4. Hematological and biochemical analysis without significant alterations that contraindicate treatment.
  • 5. Written informed consent of the patient.
  • 6. The patient is able to understand the nature of the study.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 30
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 1. Patient <18 years, or legally dependent
  • 2. Patient> 65 years
  • 3. Affected knee prior involvement in
  • 4. Intraarticular treatment in the last 6 months.
  • 5. Ligament disruption MRI image displayed on
  • 6. Infection present (for inclusion in the study should not evidenced any sign infectious).
  • 7. Congenital malformations or evolutionary translate and / or significant deformation of the knee and condition difficulties of implementation and evaluation of results.
  • 8. Excess weight expressed as body mass index (BMI) 30.5 (obesity class II). As BMI = weight (kg): (height (m)) 2
  • 9. Women who are pregnant or intend to become pregnant, or breastfeeding
  • 10. neoplastic disease
  • 11. immunosuppressive states
  • 12. Simultaneous participation in another clinical trial or treatment with another investigational product within 30 days prior to inclusion in the study.
  • 13. Other conditions or circumstances that compromise study participation medically

研究者

发起方
Parque Científico de la Universidad de Valladolid

相似试验